Chapter 5: Label Claims and the Role of Certification

Register Free: https://www.cannabissciencetech.com/cst_w/THC5

Event Overview:

Series Overview:

The quality gap is widening as more products enter the CBD market. Government regulators, industry critics, and responsible market players are well aware that many products in the market are failing to meet label claims. As competition grows in the CBD market, and as industry scrutiny increases, responsible companies must stand out by ensuring they employ industry best practices for putting credible, high-quality products on the shelf.

In this webcast series, we go back to basics: How to employ best practices in cultivation, extraction, processing, testing, and third-party certifications. Join us as we take a deep dive into the science of cannabis and what the future of excellence holds.

Webcast Overview:

Chapter 5: Label Claims and the Role of Certification

How problematic are label claims in the hemp/CBD market? And how can third-party certifications restore consumer and retailer confidence? Also, are certifications trustworthy, and is the cost of certification worth it?

Key Learning Objectives:

• Hear about the biggest label claim problems in the hemp/CBD market
• Learn about certification options from leading certifiers
• Decide whether getting certified is right for your company

Who Should Attend:

• General Management
• Legal / Regulatory
• QA/QC
• Manufacturers
• Product Development
• Marketing / Creative
• R&D

Speakers

Ashish Talati
Partner
Amin Talati Wasserman LLP

Ashish Talati leads Amin Talati Wasserman’s FDA practice and is one of the industry’s foremost experts on FDA regulatory matters. Ashish primarily counsels clients on matters of regulatory compliance, helping them anticipate and address regulatory issues in their day-to-day business operations and strategic planning. He also advocates on their behalf before the FDA, FTC, Customs, USDA, and other federal agencies. He is considered a leading authority in the areas of Generally Recognized as Safe (GRAS) requirements and New Dietary Ingredients (NDI). Considered a creative and strategic partner by his clients, Ashish works with companies all over the globe and is a trusted advisor at every step of the product life cycle, including product formulation, safety and efficacy studies, product launch, and ongoing marketing and sales.

David Trosin
Managing Director
NSF International, Health Sciences Certification

David Trosin is managing director of NSF International’s Health Sciences Certification group. In this role, he leads the ANSI-accredited certifier’s work with hundreds of dietary supplement manufacturers around the world, and he played an instrumental role in the development of the NSF/ANSI 455-2 dietary supplement GMP standard. He has worked in the dietary supplements and functional foods sector for more than 25 years.

Marielle Weintraub, PhD
President
U.S. Hemp Authority

Marielle Weintraub, PhD, is a founding board member and current president of the U.S. Hemp Authority.The U.S. Hemp Authority Certification Program is the industry’s initiative to provide high standards, best practices, and self-regulation, giving confidence to consumers, regulators, and law enforcement that hemp products can be trusted.Marielle’s career in hemp began when, following a dietary supplement conference in Boulder, CO, she brought the need for valid and reliable hemp testing to Covance Food Solutions in 2016, which later became a part of Eurofins Laboratories. Because of the rapid market shift and the rate at which the hemp industry began to grow, Marielle was focused on hemp full-time as the strategic business development director of the Hemp Initiative at Eurofins Food Integrity and Innovation. She continued to drive development of hemp-specific product testing until she left Eurofins in 2019, and continues to innovate in the hemp industry as the director of scientific research and development for Zilis.Marielle is active in many dietary supplement and hemp industry trade associations. She is a member of the Expert Review Panel and working group for AOAC’s Cannabis Analytical Science Program (CASP) – Cannabinoid Methods, board member of the U.S. Hemp Roundtable, and member of the American Herbal Products Association’s Cannabis Committee. Marielle earned her MS and PhD in behavioral neuroscience, focusing her research on Alzheimer’s disease pathology.

Register Free: https://www.cannabissciencetech.com/cst_w/THC5